Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer
Our real-world study suggests that BMI might potentially act as a predictor for ORR in patients with advanced NSCLC treated with ICIs and should be considered in treatment decision-making. Additionally, we also observed a positive trend in OS among this group of patients.
Authors
- Miloslav Pála (ORCID: https://orcid.org/0000-0002-8446-6339)
- Martin Svatoň (ORCID: https://orcid.org/0000-0002-6821-8677)
- Petr Opálka
- Daniel Krejčí
- Petra Tesařová (ORCID: https://orcid.org/0000-0003-3607-3474)
- Norbert Pauk
- Adam Šubrt
- Jana Krejčí
- Monika Šibalová
Institutions
- Charles University (CZ)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-11-29
- DOI
- https://doi.org/10.21873/anticanres.17892
- Citations
- 2
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 2.09